Brain natriuretic peptide as an integrator of cardiovascular stiffening in hypertension

International Journal of Cardiology

Volumn 141, Issue 3, 2010, Pages 291-296

  Chatzis, Dimitris ^a   Tsioufis, Costas ^a   Tsiachris, Dimitris ^a   Taxiarchou, Efstathios ^a   Lalos, Spyros ^a   Kyriakides, Zenon ^a   Tousoulis, Dimitris ^a   Kallikazaros, Ioannis ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Diastolic dysfunction; Essential hypertension; Natriuretic peptide; Pulse wave velocity

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MONITORING; CAROTID ARTERY PULSE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; FEMALE; FEMORAL ARTERY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; TISSUE DOPPLER IMAGING;

ADAPTATION, PHYSIOLOGICAL; ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING, AMBULATORY; CAROTID ARTERIES; DIASTOLE; ECHOCARDIOGRAPHY; ELASTICITY; FEMALE; FEMORAL ARTERY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PULSATILE FLOW; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77952891042     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.018     Document Type: Article

References (20)

1. Wei T., Zeng C., Chen L., et al. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. Eur J Heart Fail 7 1 (2005) 75-79
2. Freitag M.H., Larson M.G., Levy D., et al., Framingham Heart Study. Plasma brain natriuretic levels and blood pressure tracking in the Framingham Heart Study. Hypertension 41 (2003) 978-983
3. Mc Donagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
4. Bhalla M.A., Chiang A., Epshteyn V.A., et al. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol 44 (2004) 1047-1052
5. Tsioufis C., Chatzis D., Dimitriadis K., et al. Left ventricular diastolic dysfunction is accompanied by increased aortic stiffness in the early stages of essential hypertension: a TDI approach. J Hypertens 23 (2005) 1745-1750
6. Uusimaa P., Tokola H., Ylitalo A., et al., Anglo-Scandinavian Cardiac Outcomes Trial Investigators. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. Int J Cardiol 97 2 (2004) 251-256
7. Mak G.S., DeMaria A., Clopton P., and Maisel A.S. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J 148 5 (2004) 895-902
8. Schmitt M., Qasem A., McEniery C., et al. Role of natriuretic peptides in regulation of conduit artery distensibility. Am J Physiol Heart Circ Physiol 287 3 (2004) 1167-1171
9. ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 10 (2003) 1779-1786
10. Mc Cullough P.A., Nowak R.M., McCord J., et al., for the BNP Multinational Study Investigators. B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure. Circulation 106 (2002) 416-422
11. Schiller N.B., Shah P.M., Crawford M., et al. American Society of Echocardiography Committee on Standards, Subcommittee on quantication of two-dimensional echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-32267
12. Tsioufis C., Stougiannos P., Taxiarchou E., et al. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension. J Hypertens 24 (2006) 965-972
13. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the ESH/ESC. J Hypertens 25 (2007) 1105-1187
14. Sakuragi S., Okawa K., Iwasaki J., Tokunaga N., Kakishita M., and Ohe T. Aortic stiffness is an independent determinant of B-type natriuretic peptide in patients with coronary artery disease. Cardiology 107 2 (2006) 140-146
15. Yambe M., Tomiyama H., Koji Y., et al. B-type natriuretic peptide and arterial stiffness in healthy Japanese men. Am J Hypertens 19 (2006) 443-447
16. Sakuragi S., Maruo T., Taniguchi M., et al. Radial augmentation index associated with increase in B-type natriuretic peptide in patients with hypertension. Int J Cardiol 130 (2008) 414-419
17. Mehra M.R., Milani R.V., Richie M.B., et al. Ventricular-vascular uncoupling increases expression of B-type natriuretic peptide in heart transplantation. Transplant Proc 36 (2004) 391-397
18. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
19. Mitchell G.F., Izzo Jr. J.L., Lacourcière Y., et al. Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension. Results of the conduit hemodynamics of omapatrilat international research study. Circulation 105 (2002) 2955-2961
20. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150